pramipexole has been researched along with Hallucinations in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Aktürk, T; Güntekin, B; Hanoğlu, L; Hanoğlu, T; Yulug, B | 1 |
| Abbasi, MH; Esmaeili, S; Habibi, SA; Shahidi, GA | 1 |
| Cardon-Dunbar, A; Isbister, GK; Roberts, MS; Robertson, T | 1 |
| Hattori, N | 1 |
| Kataoka, H; Ueno, S | 1 |
| Keränen, T; Kuusisto, H; Tuhkasaari, M | 1 |
| Daghem, M; Grosset, DG; Grosset, KA; Macphee, GJ; Newman, EJ; Nissen, T; Odin, P; Pal, G; Stewart, M | 1 |
| Biglan, KM; Holloway, RG; McDermott, MP; Richard, IH | 1 |
| Hanna, PA; Jankovic, J; Ondo, WG; Ratkos, L | 1 |
1 review(s) available for pramipexole and Hallucinations
| Article | Year |
|---|---|
[Programs for continuing medical education: a session: 4. The pathogenesis and update for the treatments of Parkinson's disease].
Topics: Benserazide; Benzothiazoles; Catechols; Circadian Rhythm; Dementia; Dopamine Agonists; Drug Combinations; Drug Therapy, Combination; Drug Tolerance; Dyskinesias; Education, Medical, Continuing; Hallucinations; Humans; Levodopa; Nitriles; Parkinson Disease; Practice Guidelines as Topic; Pramipexole; Reference Standards; Referral and Consultation | 2014 |
2 trial(s) available for pramipexole and Hallucinations
| Article | Year |
|---|---|
Risk factors for somnolence, edema, and hallucinations in early Parkinson disease.
Topics: Adult; Age Distribution; Antiparkinson Agents; Benzothiazoles; Cognition Disorders; Cohort Studies; Comorbidity; Disorders of Excessive Somnolence; Double-Blind Method; Edema; Female; Hallucinations; Heart Diseases; Humans; Levodopa; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Pramipexole; Risk Factors; Sex Distribution | 2007 |
Switching from pergolide to pramipexole in patients with Parkinson's disease.
Topics: Accidental Falls; Aged; Aged, 80 and over; Benzothiazoles; Dopamine Agonists; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Edema; Female; Hallucinations; Humans; Male; Middle Aged; Nausea; Parkinson Disease; Pergolide; Pramipexole; Prospective Studies; Receptors, Dopamine; Sweating; Thiazoles; Treatment Outcome | 2001 |
6 other study(ies) available for pramipexole and Hallucinations
| Article | Year |
|---|---|
The therapeutic role of repetitive transcranial magnetic stimulation (rTMS) in parkinsonian visual hallucinations: Electrophysiological correlates.
Topics: Aged, 80 and over; Antiparkinson Agents; Electroencephalography; Hallucinations; Humans; Levodopa; Male; Parkinson Disease; Pramipexole; Transcranial Magnetic Stimulation | 2019 |
Dilemma in Parkinson's Treatment; Levodopa Monotherapy May be the Best Choice.
Topics: Aged; Antiparkinson Agents; Benzothiazoles; Depression; Drug Combinations; Female; Hallucinations; Humans; Levodopa; Middle Aged; Movement; Parkinson Disease; Pramipexole; Psychotic Disorders; Quality of Life | 2020 |
Pramipexole Overdose Associated with Visual Hallucinations, Agitation and Myoclonus.
Topics: Akathisia, Drug-Induced; Benzothiazoles; Dopamine Agonists; Drug Overdose; Hallucinations; Humans; Male; Middle Aged; Models, Biological; Motor Activity; Myoclonus; Pramipexole; Suicide, Attempted; Visual Perception | 2017 |
Auditory musical hallucinations associated with extended-release pramipexole in an elderly patient with Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Benzothiazoles; Female; Hallucinations; Humans; Music; Parkinson Disease; Pramipexole | 2014 |
Long-term retention rate of pramipexole in the treatment of Parkinson's disease.
Topics: Antiparkinson Agents; Benzothiazoles; Confusion; Dopamine Agonists; Finland; Hallucinations; Humans; Medication Adherence; Nausea; Netherlands; Parkinson Disease; Pramipexole; Retrospective Studies; Risk Factors | 2009 |
Duration of L-dopa and dopamine agonist monotherapy in Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Benzothiazoles; Confidence Intervals; Disorders of Excessive Somnolence; Disruptive, Impulse Control, and Conduct Disorders; Dizziness; Dopamine Agonists; Drug Therapy, Combination; Female; Hallucinations; Humans; Indoles; Kaplan-Meier Estimate; Levodopa; Male; Middle Aged; Parkinson Disease; Pramipexole; Time Factors | 2012 |